Home › Authors › Catherine Falade
Catherine Falade Quotes
born 1952 Nigeria
Catherine Olufunke Falade (née Falodun; born 25 November 1952) is a professor of pharmacology and therapeutics and also the director of the Institute for Advanced Medical Research & Training at the College of Medicine at the University of Ibadan in Nigeria. She is also a healthcare practitioner specializing as a pharmacologist at the University College Hospital, Ibadan.
Random Catherine Falade quote
22 quotes
Antibiotic resistance is present in every country. Patients with infections caused by drug-resistant bacteria are at risk of worse clinical outcomes and death.
More researches should be encouraged for non-communicable disease like malaria while rational and acceptable use of recommended drug should be encouraged.
The poor masses are also affected due to ineffective and costly way of treatment, which cannot be afforded by the parents.
They should be informed by healthcare givers, community centres, the media and all stakeholders that what the vaccine does is to reduce the attack of malaria and not to totally prevent it.
The spread of resistant strains to other parts of the world, including Nigeria, has now become a major public health challenge.
The malaria vaccine reduces prevalence, morbidity, and mortality from malaria attacks; the concern is that people take three antigens and then take the vaccines.
They consume more health-care resources than patients infected with non-resistant strains of the same bacteria.
More than 20 other vaccine constructs are currently being evaluated in clinical trials or are at an advanced pre-clinical development.
RTS, S/AS01 is the most advanced vaccine against the most deadly form of human malaria –Plasmodium falciparum.
A pharmaceutical error can wipe out a generation of people, so there is need for government to sanction producers of counterfeit malaria drugs.
The masses in Nigeria, particularly at the grassroots, need to be properly informed about this. Otherwise, Nigerians will read another meaning into the efforts of government and the World Health Organisation (WHO).
WHO has adopted these recommendations and is strongly supportive of the need to proceed with the pilots as the next step for the world’s first malaria vaccine.
In July 2015, the European Medicines Agency issued a positive scientific opinion on the vaccine’s risk-benefit balance.
In October 2015, two independent WHO advisory groups recommended the pilot implementation of RTS, S/ASO1 in parts of three to five sub-Saharan African countries.
Access to the right medicine will go a long way in assisting to stem the malaria scourge and drug manufacturers should also stick to the WHO recommended manufacturers standard.
The vaccines only reduce the risks of malaria by 35 per cent; it does not prevent malaria like other vaccines that babies take at birth for prevention of communicable diseases.
I call for coordinated action globally to minimise the emergence and spread of antimicrobial resistance to malaria and all countries need national action plans for malaria-resistant drugs.
Nigerians find faults easily in government policies and efforts geared towards their welfare.
New researches are on-going to develop new antimicrobial medicines and vaccines to tackle malaria- resistance, which has now become a burden to public health
I am even talking about pregnant women in labour who have COVID-19. That’s why I said everybody in the hospital is exposed and needs to take precaution.
Topics Catherine Falade is quoted on